Vistara Single-gene NIPT

Prenatal noninvasive test for single-gene screening

Vistara is the most comprehensive prenatal single-gene screening test for serious genetic conditions. These conditions, which affect quality of life, could benefit from early intervention and might otherwise go undetected.

Vistara> tests 25 serious genetic diseases, with a single blood sample taken from the mother. The results will be sent to the doctor in 2-3 weeks.

Vistara is the only NIPT that brings clinically relevant information about the health of the fetus.

Information obtained as early as possible during pregnancy leads to proper medical management.

Screen for 25 autosomal dominant and X-linked conditions across 30 genes with Vistara single-gene NIPT

  • Provide clinically actionable information:
    • Many single-gene conditions benefit from early intervention
    • Inform decisions for pregnancy and delivery management, early interventions, and patient education to ensure every child reaches their full potential
  • Perform testing with ease and get clear results
    • No paternal and/or egg-donor* sample necessary
    • Find conditions other screening modalities would miss until after the window for critical intervention

*if applicable

Vistara screens conditions with a combined incidence greater than Down syndrome1,2

All pregnancies can benefit from Vistara

Some scenarios where single-gene NIPT should be considered

Couples with a male partner over 40-years-old

Ultrasound anomalies including shortened long bones and increased nuchal translucency

Family history of hereditary conditions

Patients who want as much information as possible

No errors detected in clinical validation

Vistara’s clinical validation published in Nature Medicine (Zhang et al) showed the following performance metrics:2

  • >99% sensitivity
  • >99% specificity

Make confident pregnancy management and early intervention decisions with performance you can trust.

Vistara single-gene NIPT:

  • Has one of the most comprehensive Noonan panels available
  • Screens for conditions that are not included in standard diagnostic


1Snijders, et al. Ultrasound Obstet Gynecol 1999;13:167-170.

2Zhang J et al. Nat Med. 2019 Mar;25(3):439-447.

3Pagon RA et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.